Rutin suppresses human-amylin/hIAPP misfolding and oligomer formation in-vitro, and ameliorates diabetes and its impacts in human-amylin/hIAPP transgenic mice. [electronic resource]
- Biochemical and biophysical research communications Jan 2017
- 625-631 p. digital
Publication Type: Journal Article
1090-2104
10.1016/j.bbrc.2016.11.083 doi
Amyloid--genetics Animals Blood Glucose--metabolism Diabetes Mellitus, Experimental--drug therapy Diabetes Mellitus, Type 2--drug therapy Humans Hypoglycemic Agents--pharmacology Islet Amyloid Polypeptide--genetics Islets of Langerhans--drug effects Male Mice, Transgenic Protein Aggregation, Pathological--drug therapy Protein Folding--drug effects Proteostasis Deficiencies--drug therapy Rutin--pharmacology